高级检索
当前位置: 首页 > 详情页

Outcomes of 48 patients with primary angioimmunoblastic T-cell lymphoma in real-world clinical practice: a single-center experience

| 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Hematology,The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, PR China [2]Department of Clinic Laboratory, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, PR China
出处:
ISSN:

关键词: Angioimmunoblastic T-cell lymphoma efficacy survival analysis adverse events

摘要:
Angioimmunoblastic T-cell lymphoma (AITL) is a rare cancer of the lymphatic system. There is no effective chemotherapy regimen for long-term survival. The traditional chemotherapy regimen consists of cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP). This study evaluated the outcomes of a cyclophosphamide, doxorubicin, vincristine, prednisolone, and thalidomide (CHOP-T) regimen for patients with primary AITL. Clinical data of 48 primary AITL patients treated with CHOP-T or CHOP regimens were retrospectively analyzed. The 2-year overall survival (OS) and progression-free survival (PFS) rates of all patients were 52.8% and 36.6%, respectively. The 2-year OS rates of the CHOP-T group were better than that of the CHOP group (70.6% vs. 44.6%, P=0.045). However, this did not translate into significantly better PFS (P=0.122) or complete remission (CR) rates (P=0.068). Multiple-factor analysis showed that positive Coombs tests and bone marrow infiltration were independent prognostic factors of PFS. Only a positive Coombs test tended to be associated with lower OS rates. There were no statistically significant differences in hematologic toxicity between the two groups (P=0.299). Non-hematological toxicity in the CHOP-T group, such as diarrhea, peripheral neuropathy, and somnolence/fatigue, was significantly higher than in the CHOP group (P=0.017). The present study showed that the CHOP-T regimen was more effective than the CHOP regimen in improving OS and CR rates, but non-hematological toxicities were higher. Severity of diarrhea, peripheral neuropathy, and somnolence/fatigue was significantly associated with thalidomide and no efficient precautions were observed.

语种:
WOS:
中科院分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
JCR分区:
出版当年[2019]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2024]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2024版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版]

第一作者:
第一作者机构: [1]Department of Hematology,The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, PR China
通讯作者:
通讯机构: [1]Department of Hematology,The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, PR China [*1]Department of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, PR China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42313 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号